Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Corcept Therapeutics reported $7.51M in Stock for its fiscal quarter ending in September of 2023.

Stock Change Date
Acadia Pharmaceuticals USD 20.77M 11.57M Sep/2023
ANI Pharmaceuticals USD 106.59M 2.27M Sep/2023
Assertio Holdings USD 13.7M 572K Dec/2022
Aurora Cannabis CAD 128.82M 6.23M Mar/2023
BioMarin Pharmaceutical USD 894.08M 54.62M Dec/2022
Bristol-Myers Squibb USD 2.44B 72M Sep/2023
Canopy Growth CAD 87.47M 54.59M Sep/2023
Corcept Therapeutics USD 7.51M 8.16M Sep/2023
Eli Lilly USD 4.31B 478.6M Dec/2022
Esperion Therapeutics USD 35.2M 5.66M Dec/2022
Knight Therapeutics CAD 92.49M 7.55M Dec/2022
Merck USD 5.91B 297M Dec/2022
Nektar Therapeutics USD 19.2M 145K Dec/2022
Novartis USD 7.18B 396M Dec/2022
Novartis USD 6.67B 465M Dec/2021
Omeros USD 712K 266K Sep/2021
Pacira USD 96.52M 4.39M Sep/2023
Pfizer USD 8.98B 532M Dec/2022
Supernus Pharmaceuticals USD 83.48M 7.08M Sep/2023